Skip to main content
Clinical Trials/KCT0003181
KCT0003181
Active, Not Recruiting
N/A

Exploration of pathophysiologic mechanism of cerebrovascular disease as a risk factor of dementia using blood-brain barrier imaging and genomics

Konkuk University Medical Center0 sites88 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Diseases of the nervous system
Sponsor
Konkuk University Medical Center
Enrollment
88
Status
Active, Not Recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Observational Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\)Patients with Dementia due to AD or MCI due to AD (intermediate to high biomarker probability) according to the NIA\-AA diagnostic guidelines (2011\).Informed consent before participation in the study
  • 2\)In case of patient with dementia, Clinical dementia rating (CDR) of 0\.5 or 1, which means a mild stage of dementia
  • 3\)Age of 45\-80
  • 4\)Informed consent understood, signed and patient agrees to all follow\-up visits.

Exclusion Criteria

  • 1\) Contraindications for scanning (e.g. brain surgery, cardiac pacemaker, metal implants, claustrophobia, large body tattoos)
  • 2\) Contraindications for contrast agent Gadovist (renal failure) as determined by the estimated Glomular Filtration Rate eGFR \< 30 mL/min.
  • 3\) Major vascular disorders (e.g. stroke, heart disease)
  • 4\) Psychiatric or neurological disorders: Major depression (\< 12 months); history of schizophrenia; bipolar disorder; psychotic disorder NOS or treatment for a psychotic disorder (\< 12 months); cognitive impairment due to alcohol abuse; epilepsy; Parkinson's disease; MS; brain surgery; brain trauma; electroshock therapy; kidney dialysis; Meniere's disease; and brain infections.
  • 5\) Structural abnormalities of the brain
  • 6\) Cognitive impairment due to alcohol/drug abuse
  • 7\) Absence of reliable informant (for patient groups)

Outcomes

Primary Outcomes

Not specified

Similar Trials